Boring CC, Squires TS, Heath CW Jr. Cancer statistics for African Americans. CA Cancer J Clin . 1992;;42:7-17.
Boring CC, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer J Clin . 1992;;42:19-38.
Aziz H, Rotman M, Thelmo W, et al. Radiation-treated carcinoma of prostate: comparison of survival of black and white patients by Gleason's Grading System. Am J Clin Oncol . 1988;;11:166-171.
Dayal HH, Power RN, Chiu C. Race and socioeconomic status in survival from breast cancer. J Chronic Dis . 1982;;35:675-683.
Ownby HE, Frederick J, Russo J, et al. Racial differences in breast cancer patients. J Natl Cancer Inst . 1985;;75:55-60.
Bain RP, Greenberg RS, Whitaker JP. Racial differences in survival of women with breast cancer. J Chronic Dis . 1986;;39:631-642.
Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health . 1986;;76:1400-1403.
Dansey RD, Hessel PA, Browde S, et al. Lack of a significant independent effect of race on survival in breast cancer. Cancer . 1988;;61:1908-1912.
Dayal H, Polissar L, Yang CY, Dahlberg S. Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer. J Chronic Dis . 1987;;40:857-864.
Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer . 1992;;69:2349-2360.
Steinhorn SC, Myers MH, Hankey BF, Pelham VF. Factors associated with survival differences between black women and white women with cancer of the uterine corpus. Am J Epidemiol . 1986;; 124:85-93.
Bain RP, Greenberg RS, Chung KC. Racial differences in survival of women with endometrial cancer. Am J Obstet Gynecol . 1987;;157:914-923.
Klingemann H-G, Deeg HJ, Self S, Thomas ED, Storb R. Is race a risk factor for allogeneic marrow transplantation? Bone Marrow Transplant . 1986;;1: 87-94.
Reintgen DS, McCarty KM Jr, Cox E, Seigler HF. Malignant melanoma in black American and white American populations. JAMA . 1982;;248:1856-1859.
Ragland KE, Selvin S, Merrill DW. Black-white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol . 1991;; 133:672-682.
Broder S. The challenge of cancer research. Stem Cells . 1993;;11:3-8.
Walters TR, Bushore M, Simone J. Poor prognosis in negro children with acute lymphocytic leukemia. Cancer . 1972;;29:210-214.
Reaman GH, Leikin SL. Racial variation in the frequency of immunological subtypes of childhood acute lymphoblastic leukemia. Prog Cancer Res Ther . 1984;;27:163-168.
Sather H, Honour R, Sposto R, Level C, Hammond D. Differences in the presentation of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in black children and white children: a report from the Epidemiology Committee of the Children's Cancer Study Group. Prog Cancer Res Ther . 1984;;27:179-187.
Falletta JM, Boyett J, Pullen DJ, et al. Clinical and phenotypic features of childhood acute lymphocytic leukemia in whites, blacks, and Hispanics: a Pediatric Oncology Group study. Prog Cancer Res Ther . 1984;;27:191-195.
Kalwinsky DK, Rivera G, Dahl GV, et al. Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: implications for treatment outcome. Leuk Res . 1985;; 9:817-823.
Young JL, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer . 1986;;58:598-602.
Birch JM, Marsden HB, Morris Jones PH, Pearson D, Blair V. Improvements in survival from childhood cancer: results of a population based survey over 30 years. BMJ . 1988;;296:1372-1376.
Pediatric Oncology Group. Progress against childhood cancer: the Pediatric Oncology Group experience. Pediatrics . 1992;;89:597-600.
Cox DR, Lewis PAW. The Statistical Analysis of Series of Events . London, England: Methuen & Co Ltd; 1968;:229-237.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc . 1958;;53:457-481.
Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer . 1977;;35:1-39.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst . 1958;;22:719-748.
Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer: Worldwide Evidence 1985-1990 . New York, NY: Oxford University Press Inc; 1990:1.
Miller RW. Frequency and environmental epidemiology of childhood cancer. In: Pizzo RA, Poplack DG, eds. Principles and Practice of Pediatric Oncology . Philadelphia, Pa: JB Lippincott; 1989;:3-18.
Pui C-H, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood . 1993;;82:343-362.
Pui C-H, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood . 1990;; 76:1449-1463.
Pui C-H, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med . 1991;;325:1682-1687.
Evans WE, Rodman J, Relling MV, et al. Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. Semin Hematol . 1991;;28:15-21.
Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM. Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med . 1993;;329:1289-1295.
Kitagawa EM, Hauser PM. Differential Mortality in the United States: A Study in Socioeconomic Epidemiology . Cambridge, Mass: Harvard University Press; 1973;.
Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med . 1993;;324:103-109.
Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med . 1991;; 324:808-815.
Neglia JP, Meadows AT, Robison LL, et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med . 1991;;325:1330-1336.
Blatt J, Olshan A, Gula MJ, Dickman PS, Zaranek B. Second malignancies in very-long-term survivors of childhood cancer. Am J Med . 1992;;93: 57-60.
Meadows AT, Kramer S, Hopson R, Lustbader E, Jarrett P, Evans AE. Survival in childhood acute lymphocytic leukaemia: effect of protocol and place of treatment. Cancer Invest . 1983;;1:49-55.
Kramer S, Meadows AT, Pastore G, Jarrett P, Bruce D. Influence of place of treatment on diagnosis, treatment and survival in three pediatric solid tumors. J Clin Oncol . 1984;;2:917-923.
Lennox EL, Stiller CA, Morris Jones PH, Kinnier LWM. Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. BMJ . 1979;;2:567-569.
Stiller CA. Centralisation of treatment and survival rates for cancer. Arch Dis Child . 1988;;63:23-30.
Angell M. Privilege and health—what is the connection? N Engl J Med . 1993;;329:126-127.
Novakovic B. U.S. childhood cancer survival, 1973-1987. Med Pediatr Oncol . 1994;;23:480-486.